艾美捷科技特约代理BioPorto Diagnostics A/S公司产品。

BioPorto Diagnostics A/S公司成立于2001年，是丹麦一家专门生产抗体和基于抗体的各种生物产品的公司。BioPorto拥有Bioporto Diagnostics和Antibodyshop两个品牌，分别侧重于诊断试剂盒和抗体产品。在30多个国家有代理商，产品销售网络遍布全球，99%以上为出口销售。BioPorto Diagnostics旗下产品主要为几种临床快速诊断试剂盒，包括诊断早期急性肾损伤的NGAL ELISA kit，Gc-globulin ELISA kit ，评估原发性免疫缺陷的MBL Oligomer ELISA kit，同时还有相关其他种属的科研用试剂盒和抗原抗体。其最新推出的产品有检测人体血浆中的活性蛋白C-蛋白C抑制物(APC-PCI)复合物的APC-PCI ELISA kit，高纯度人IgE单克隆抗体，以及Glucagon-like peptide-1和Exendin-4相关的单抗。

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. We sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.

ApexBio Technology LLC 在生物研究肽和实验室试剂中首屈一指。ApexBio在许多研究领域都具有广泛的产品线，例如：遗传学，细胞凋亡，肿瘤生物学等。ApexBio还提供各种定制服务，包括肽的合成，抗体的产生和发展分析。

ApexBio is a premier provider of peptides and lab reagents for biological research. We carry a broad product line in research areas such as Apoptosis, Epigenetics, Cancer Biology and so on. Apexbio also provides custom services including peptide synthesis, antibody production and assay development.

ApexBio的主要产品包括：

Drug Screening Library

Drug Screening Panel

DNA/RNA Prep Kit

Biotinylation Reagents

Biochemicals

Bioactive Peptides

Tag Peptides

Growth Factors

Amino Acids & Building Blocks

Allele Biotechnology位于美国圣地亚哥市，主要专注于对生物过程的机制进行探索，以开发生物医学及治疗相关的技术和产品。以各个物种的iPS细胞、人类cGMP iPS细胞及衍生的细胞为材料，Allele Biotechnology利用专利性的非整合细胞编辑方法，开发了出了细胞治疗和药物筛选的技术。Allele Biotechnology具有深厚的基因组修饰和细胞荧光报告因子的经验，为客户提供优异的细胞检测解决方案。Allele Biotechnology还提供荧光蛋白、高效荧光素酶底物、基因分型试剂盒、骆驼抗体等产品；此外还在RNA干扰领域尤其独特的专利。

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical research and therapy development.

Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge technologies in individual products and fully integrated platforms. Allele utilizes proprietary non-integrating cellular reprogramming methods to develop cell therapy and enable drug discovery through the use of human and non-human primate iPS cells, cGMP-grade human iPS cells and their derivatives. With additional expertise in genome modification and unique cell-based fluorescence sensors/reporters, Allele provides advanced cell and assay development solutions. Allele also has developed a wide variety of advanced research tools including superior fluorescent proteins, highly efficient luciferase assay substrates, genotyping kits, and camelid antibodies that have been validated for co-immunoprecipitation, histology, and flow cytometry. The Company has also been a leader in the RNAi field with its patents in Pol III promoter-driven siRNA, shRNA, and miRNA.